Morgan Stanley’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Sell |
785,377
-1,394,265
| -64% | -$3.78M | ﹤0.01% | 4658 |
|
|
2025
Q1 | $4.9M | Sell |
2,179,642
-1,374,592
| -39% | -$3.09M | ﹤0.01% | 3946 |
|
|
2024
Q4 | $12.4M | Buy |
3,554,234
+1,206,409
| +51% | +$4.22M | ﹤0.01% | 3220 |
|
|
2024
Q3 | $9.65M | Buy |
2,347,825
+2,140,089
| +1,030% | +$8.8M | ﹤0.01% | 3457 |
|
|
2024
Q2 | $748K | Sell |
207,736
-1,174,953
| -85% | -$4.23M | ﹤0.01% | 5122 |
|
|
2024
Q1 | $4.56M | Buy |
1,382,689
+1,230,359
| +808% | +$4.06M | ﹤0.01% | 3981 |
|
|
2023
Q4 | $352K | Buy |
152,330
+145,637
| +2,176% | +$336K | ﹤0.01% | 5748 |
|
|
2023
Q3 | $8.63K | Sell |
6,693
-2,326
| -26% | -$3K | ﹤0.01% | 6783 |
|
|
2023
Q2 | $11.9K | Hold |
9,019
| – | – | ﹤0.01% | 6750 |
|
|
2023
Q1 | $6.38K | Sell |
9,019
-18,430
| -67% | -$13K | ﹤0.01% | 7002 |
|
|
2022
Q4 | $20.6K | Sell |
27,449
-121,642
| -82% | -$91.2K | ﹤0.01% | 6688 |
|
|
2022
Q3 | $129K | Buy |
149,091
+43,954
| +42% | +$38K | ﹤0.01% | 5945 |
|
|
2022
Q2 | $118K | Sell |
105,137
-68,687
| -40% | -$77.1K | ﹤0.01% | 6191 |
|
|
2022
Q1 | $195K | Sell |
173,824
-34,844
| -17% | -$39.1K | ﹤0.01% | 5936 |
|
|
2021
Q4 | $334K | Buy |
208,668
+187,526
| +887% | +$300K | ﹤0.01% | 5788 |
|
|
2021
Q3 | $51K | Sell |
21,142
-34,449
| -62% | -$83.1K | ﹤0.01% | 6712 |
|
|
2021
Q2 | $177K | Buy |
55,591
+11,520
| +26% | +$36.7K | ﹤0.01% | 6074 |
|
|
2021
Q1 | $149K | Buy |
44,071
+39,971
| +975% | +$135K | ﹤0.01% | 5815 |
|
|
2020
Q4 | $15K | Sell |
4,100
-1,300
| -24% | -$4.76K | ﹤0.01% | 6527 |
|
|
2020
Q3 | $14K | Buy |
5,400
+3,067
| +131% | +$7.95K | ﹤0.01% | 6165 |
|
|
2020
Q2 | $7K | Buy |
2,333
+1,833
| +367% | +$5.5K | ﹤0.01% | 6244 |
|
|
2020
Q1 | $1K | Sell |
500
-1,716
| -77% | -$3.43K | ﹤0.01% | 6470 |
|
|
2019
Q4 | $8K | Sell |
2,216
-24,196
| -92% | -$87.4K | ﹤0.01% | 6316 |
|
|
2019
Q3 | $79K | Buy |
26,412
+13,070
| +98% | +$39.1K | ﹤0.01% | 5527 |
|
|
2019
Q2 | $34K | Buy |
+13,342
| New | +$34K | ﹤0.01% | 5754 |
|